(team)
People who connect science and strategy.
Aether brings together leaders with experience in pharmaceutical development, intellectual property, and scientific management, supported by a committee of researchers specialized in different therapeutic areas.
Who leads the platform.
Patricia P. Oliveira
With more than 25 years of experience in the pharmaceutical industry and highly regulated environments, Patricia P. Oliveira has built her career at the intersection of pharmaceutical development, regulatory strategy, technology transfer, and industrial operations.
Her experience spans work alongside ANVISA and international authorities, as well as leading projects, industrial operations, and technology development initiatives at national and multinational organizations.
As founder and CEO of Aether Global Pharma and president of ICT AetherBio+, she leads an integrated Pharmaceutical Asset Venture Building platform, connecting high-potential science, intellectual property, capital, and industry to build, develop, and add value to pharmaceutical assets with global potential.
(featured achievements)
More than 300 products approved by ANVISA
Certification of the Hib vaccine PMT fraction production line at TECPAR
International certifications for export to highly regulated markets
Implementation of a hyaluronic acid plant in Pinhais
Leadership of industrial operations and teams with more than 200 professionals in a GMP environment
Let's build the next generation of pharmaceutical assets.
We're looking for researchers, universities, companies, investors, and strategic partners committed to turning excellent science into therapeutic solutions with global impact.